Minireviews
Copyright ©The Author(s) 2021.
World J Hepatol. Sep 27, 2021; 13(9): 1154-1166
Published online Sep 27, 2021. doi: 10.4254/wjh.v13.i9.1154
Table 1 Effects of probiotics on different disorders in experimental alcoholic liver disease
Disorder
Biomarker changes
Ref.
Liver steatosis↓ Liver mass, ↓ content of triglycerides, free fatty acids, and cholesterol in the liver tissues[50-52,54]
Liver inflammation↓ Myeloperoxidase activity, expression of tumor necrosis factor alpha gene and neutrophil infiltration in the liver[54]
Oxidative stress in liver↓ Level of nitric oxide and malondialdehyde and ↑ level of glutathione and catalase in the liver tissue[50,51,54]
Death of hepatocytes↓ Serum aminotransferases[50-54]
Systemic inflammation↓ Serum IL-6 and tumor necrosis factor alpha[51-53]
Bacterial translocation↓ Serum lipopolysaccharide[51-54]
Gut dysbiosis↑ Firmicutes, Clostridiales and Lactobacillales; ↓ Proteobacteria and Campylobacterales[51,53]
Damage to the intestinal epithelium↓ Serum diamine oxidase[53]
Increased intestinal permeability↓ Serum D-lactate, ↑ the amount of occludin and other protein of tight junction in the gut epithelium, ↓ intestinal permeability for dyes[50,52-54]
Dyslipidemia↓ Serum cholesterol and triglycerides[50,52-54]
Table 2 Effects of probiotics on different disorders in experimental metabolic associated fatty liver disease
Disorder
Biomarker changes
Ref.
Liver steatosis↓ Liver mass, the size and number of lipid droplets, the content of triglycerides, free fatty acids, and cholesterol in the liver tissues[60-66]
Obesity↓ Body mass, subcutaneous fat[61-63,65,66]
Intensified lipogenesis↓ Expression of the genes of sterol regulatory element-binding protein 1c (SREBP-1c), 3-hydroxy-3-methylglutaryl-CoA reductase, acetyl-CoA carboxylase 1, acetyl-CoA acetyltransferase 2, and fatty acid synthase, ↑ activated 5' adenosine monophosphate-activated protein kinase (SREBP-1c inhibitor)[60,62,65,66]
Reduced lipolysis↑ Expression of the gene of peroxisome proliferator-activated receptor alpha (fatty acid catabolism enhancer) and acyl-CoA oxidase [60,62]
Bile acid metabolism disorders↑ Expression of the gene of bile salt export pump, farnesoid X recetor, cholesterol 7a-hydroxylase, sodium taurocholate cotransporting polypeptide, ↓ the content of bile acids in the liver tissues[62]
Oxidative stress↓ Total reactive oxygen species, lipid peroxidates, and malondialdehyde and ↑ glutathione, superoxide dismutase, and catalase in the liver tissue[60,61,65,66]
Liver inflammation↓ Expression of the genes of tumor necrosis factor alpha, interleukin 1-beta and 6 and the content of NF-κB in the liver[60]
Death of hepatocytes↓ Serum aminotransferases[60,61,65]
Insulin resistance↓ HOMA-IR, insulin, resistin[63,64]
Systemic inflammation↓ Serum tumor necrosis factor alpha, interleukin 1-beta and 6[60,64]
Bacterial translocation↓ Serum lipopolysaccharide[64]
Increased gut permeability↑ Amount of proteins of tight junction in the gut[64]
Disorders of the metabolism of carbohydrates and lipids↓ Serum total cholesterol, low density lipoprotein cholesterol, glucose, triglycerides, and free fatty acids, ↑ expression of the gene of low-density lipoprotein receptor[60-62,65,66]